uracil has been researched along with estramustine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Kusuyama, H; Numa, H; Okada, K; Sakamoto, S | 1 |
| Akaza, H; Tsukamoto, S | 1 |
| Fukui, T; Harada, Y; Imazu, T; Miki, T; Nishimura, K; Nonomura, N; Nozawa, M; Okuyama, A; Ono, Y; Sugao, H; Takaha, N | 1 |
| Arai, Y; Ichikawa, Y; Inoue, H; Kamoi, K; Koide, T; Miki, T; Miura, H; Nakai, Y; Nishimura, K; Nonomura, N; Okuyama, A; Shimizu, K; Sugao, H; Takaha, N; Takatera, H; Tokizane, T; Uchida, K; Ukimura, O; Yamaguchi, S | 1 |
| Kume, H | 1 |
| Ezaki, T; Hayakawa, N; Maeda, T; Matsumoto, K; Nakamura, S; Ninomiya, A; Sakamoto, H; Sato, A | 1 |
2 review(s) available for uracil and estramustine
| Article | Year |
|---|---|
[Progress in oral anti-cancer drug therapy for urological cancer].
Topics: Administration, Oral; Androgen Antagonists; Antineoplastic Agents, Hormonal; Drug Administration Schedule; Drug Combinations; Estramustine; Etoposide; Female; Flutamide; Humans; Kidney Neoplasms; Male; Prostatic Neoplasms; Tegafur; Uracil; Urinary Bladder Neoplasms | 1999 |
[Hormonal chemotherapy for hormone-refractory prostate cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Drug Administration Schedule; Drug Combinations; Estramustine; Humans; Male; Middle Aged; Prostatic Neoplasms; Tegafur; Uracil | 2002 |
2 trial(s) available for uracil and estramustine
| Article | Year |
|---|---|
Oral combination of cyclophosphamide, uracil plus tegafur and estramustine for hormone-refractory prostate cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Androgen Antagonists; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Estramustine; Humans; Lymphatic Metastasis; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Tegafur; Treatment Outcome; Uracil; Urination | 2001 |
[Hormonal chemotherapy for hormone-refractory prostate cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Drug Administration Schedule; Drug Combinations; Estramustine; Humans; Male; Middle Aged; Prostatic Neoplasms; Tegafur; Uracil | 2002 |
4 other study(ies) available for uracil and estramustine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Lung metastases of prostatic cancer vanished by early combined hormonal and chemotherapy: report of a case].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Estramustine; Humans; Lung Neoplasms; Male; Methotrexate; Orchiectomy; Prostatic Neoplasms; Proteoglycans; Tegafur; Uracil | 1989 |
[Oral antineoplastic agents for prostate cancer].
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Estramustine; Humans; Male; Oxonic Acid; Prostatic Neoplasms; Tegafur; Uracil | 2011 |
Efficacy of tegafur-uracil (UFT) administration in castration-resistant prostate cancer patients with a history of both alternative antiandrogen therapy and estramustine phosphate sodium hydrate therapy.
Topics: Age Factors; Aged; Aged, 80 and over; Androgen Antagonists; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Disease Progression; Drug Combinations; Estramustine; Exanthema; Humans; Male; Middle Aged; Nausea; Neoplasm Grading; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Tegafur; Uracil | 2014 |